rs11199879: Understanding This Genetic Variant and Prostate Health
The rs11199879 variant is a common genetic change located in an intergenic region of the human genome. It has been identified in scientific studies as having a statistical association with serum prostate-specific antigen (PSA) levels and the aggressiveness of prostate cancer.
What each genotype means
Baseline PSA association
This genotype is associated with baseline serum prostate-specific antigen (PSA) levels. Research indicates this variant may also correlate with prostate cancer aggressiveness, though these associations are statistical in nature and do not predict individual health outcomes.
This is a common genotype found across diverse global populations.
Baseline PSA association
This genotype is associated with baseline serum prostate-specific antigen (PSA) levels. Research indicates this variant may also correlate with prostate cancer aggressiveness, though these associations are statistical in nature and do not predict individual health outcomes.
This is a common genotype found across diverse global populations.
Baseline PSA association
This genotype is associated with baseline serum prostate-specific antigen (PSA) levels. Research indicates this variant may also correlate with prostate cancer aggressiveness, though these associations are statistical in nature and do not predict individual health outcomes.
This is a common genotype found across diverse global populations.
What is rs11199879?
The rs11199879 variant is a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This specific SNP is classified as intergenic, meaning it is located in the non-coding DNA between genes rather than within a gene that provides instructions for making proteins. Because it sits in a non-coding region, researchers often investigate whether such variants influence the regulation of nearby genes or affect how the genome is structured. In the context of large-scale genetic studies, rs11199879 is tracked as a marker that may help scientists understand the complex genetic architecture underlying prostate health. It is important to note that being an intergenic variant, it does not directly alter a protein sequence, but rather serves as a statistical signal in the study of inherited traits.
Associations with Prostate Health
Research published in the GWAS Catalog and related literature has linked rs11199879 to variations in serum PSA levels and the clinical aggressiveness of prostate cancer. Prostate-specific antigen is a protein produced by the prostate gland, and its levels are frequently measured in clinical settings to screen for prostate issues. While the evidence for this association is considered moderate, it highlights the ongoing effort to identify common genetic variants that contribute to the risk of prostate cancer. These studies typically compare the genomes of individuals with and without specific health outcomes to find patterns. It is crucial to understand that these associations are statistical in nature, meaning they describe trends across large populations rather than predicting an individual's specific health outcome. Genetic risk is only one piece of a much larger puzzle that includes age, family history, and environmental factors.
Population Frequency and Interpretation
The rs11199879 variant is documented as a common SNP, meaning it appears frequently across various human populations. In genetic research, common variants are often the focus of genome-wide association studies (GWAS) because they are easier to detect and analyze in large cohorts. However, the frequency of such variants can vary significantly between different ancestral groups. When interpreting data about common variants, scientists look for consistent signals across diverse populations to confirm the validity of the association. If you have received information about your genotype for this variant, it is important to view it as a small data point within the context of your overall health. Because the association is moderate and the variant is common, it does not serve as a diagnostic tool. Always consult with a healthcare professional or a genetic counselor to discuss how genetic information relates to your personal health history and screening needs.
What You Can Do With This Information
Understanding your genetic profile can be an educational experience, but it is not a substitute for professional medical advice. If you are concerned about prostate health, the most effective steps involve regular communication with your doctor regarding appropriate screening schedules based on your age, family history, and other clinical risk factors. Genetic variants like rs11199879 are currently used primarily in research settings to better understand the biological mechanisms of disease. They are not typically used in routine clinical practice to make individual treatment decisions. If you have questions about your risk for prostate cancer, ask your physician about established screening guidelines. Do not make changes to your health management or medical care based solely on the presence of a single genetic variant. Your clinician can provide the necessary context to interpret your health status accurately and recommend evidence-based steps for your long-term wellness.
How common is this variant?
The rs11199879 variant is considered a common SNP, with its specific allele frequencies distributed across global populations as documented in large-scale genomic databases.
Frequently asked questions
Is rs11199879 a diagnostic test for prostate cancer?
No, rs11199879 is not a diagnostic test. It is a genetic variant associated with statistical trends in research, not a clinical tool for diagnosing cancer.
Should I be worried if I have the GG genotype?
Genetic variants are only one factor in health. You should discuss your overall prostate cancer risk, including family history and screening, with your doctor.
Where can I find more information on this SNP?
You can search for rs11199879 on the NCBI dbSNP database or the GWAS Catalog to see the latest research and study results.
Does this variant affect how I should take medication?
There is no evidence that this variant affects medication response. Always consult your clinician or pharmacist regarding any questions about your medications.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11199879?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
This variant has been identified as a shared genetic signal between longevity and Alzheimer's disease risk.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
This SNP is linked to cardiovascular disease prevention strategies and personalized nutritional approaches.
This polymorphism in the arachidonate 5-lipoxygenase gene is investigated for its potential influence on cardiovascular disease risk and dietary response.